PATH - women leaders building multi-sectoral partnerships for global health

Add this event to your calendar:
13/10/2017 10:00 13/10/2017 12:00 America/Los_Angeles PATH - women leaders building multi-sectoral partnerships for global health Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA JLABS Bay Area false DD/MM/YYYY

PATH - women leaders building multi-sectoral partnerships for global health

Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA

October 13, 2017 from 10:00 AM to 12:00 PM (PST)

$10 - $35

Program Overview:
Join members of PATH's executive team and Zambia country leader to learn about building multi-sectoral partnerships in healthcare. These global health leaders will tell personal stories about cultivating relationships with governments, business leaders, and other nonprofits to develop and deliver products and technologies to address the world's greatest unmet health needs. This informal panel of leaders will share their experience across a variety of countries and cultures including the universal, unique, or surprising challenges they've encountered throughout their careers.

PATH is the leader in global health innovation. An international nonprofit organization, PATH saves lives and improves health, especially among women and children. PATH accelerates innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—that harness their entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, PATH takes innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs.

Headquartered in Seattle, Washington, PATH has 1,600 employees, over 2,000 partners worldwide, and an annual budget of US$330 million. PATH works with companies to create market-based solutions through tailored partnership opportunities that deliver measurable impact. PATH matches each company's resources and expertise with their unique strengths to accelerate the next generation of lifesaving innovations. Visit for more details.

PATH representative presenting: Amie Batson, Chief Strategy Officer and Vice President, Strategy and Learning; Kathy Cahill, Vice President, International Development; Nanthalile Mugala, Country Director, Zambia.

Amie Batson, MBA | Chief Strategy Officer and Vice President, Strategy and Learning, PATH read bio»
Kathy Cahill, MPH
| Vice President, International Development, PATH read bio»
Nanthalile Mugala, MD, MMed | Country Director, Zambia, PATH read bio»

8:00AM | Registration, Breakfast, and Networking
8:30 AM | Panel Discussion
9:30 AM | Networking
10:00 AM | Program Close


$5 | General Public

Speakers' Biographies:

Amie Batson, MBA | Chief Strategy Officer and Vice President, Strategy and Learning, PATH

Amie Batson, MBA, is our chief strategy officer, responsible for guiding PATH's strategy, strengthening our partnerships and business relationships in the global health community. She is also our vice president of Strategy and Learning, overseeing our work in Market Dynamics and in Results Management, Measurement, and Learning.

Ms. Batson's 20-year career in global health includes positions with the World Health Organization, UNICEF, the World Bank, and most recently, the US Agency for International Development (USAID), where she served as senior deputy assistant administrator for global health.

During her three-year appointment with USAID, Ms. Batson led the agency's engagement in the President's Global Health Initiative, represented the US government on the board of the GAVI Alliance, and led the US government team in coconvening the Child Survival Call to Action, which launched the global vision to end preventable child deaths.

Throughout her career in global health, Ms. Batson has been a leader in innovation. Her contributions to immunization and vaccine financing at the World Bank resulted in billions of dollars in new funding for global health and the vaccination of millions of children against polio, pneumonia, diarrhea, and other vaccine-preventable causes of death.

Ms. Batson earned a BA in economics from the University of Virginia and a MBA from the Yale University School of Management.

Kathy Cahill, MPH | Vice President, International Development, PATH

Kathy Cahill is PATH's vice president of International Development. In this role, she oversees our global network of country-based programs, optimizing PATH's public health impact in any given country and bolstering the sustainability of our programmatic portfolio across countries.

Ms. Cahill has more than 20 years of experience in public health, with a background in strategy leadership of programs for sexually transmitted infections, childhood immunization, HIV, noncommunicable diseases, and maternal and child health. She is the senior partner and founder of AHISMA Group, a global health company focused on health systems strengthening, policy development, program assessment, and monitoring and evaluation of infectious and noncommunicable disease programs in low-resource settings.

Previously, Ms. Cahill served as our interim vice president for Public Health Impact. Before joining PATH in 2014, she served as deputy director of Integrated Health Solutions for Global Health at the Bill & Melinda Gates Foundation and at the US Centers for Disease Control and Prevention as director for Policy, Planning, and Evaluation and division director for Immunization Service Delivery.

Ms. Cahill received an MPH from the University of North Carolina at Chapel Hill and a BA from Central Washington University.

Nanthalile Mugala, MD, MMed | Country Director, Zambia, PATH

Nanthalile Mugala is the country director for PATH's Zambia program. She oversees all operations in the country and serves as a liaison between PATH Zambia, PATH headquarters, donors, partners, national-level ministries.

Dr. Mugala has more than 20 years of experience implementing programs and services related to HIV, malaria, reproductive health, child and newborn health, and nutrition. She previously worked as pediatrician at a hospital in Lusaka and served as president of the National Pediatric Association. She has contributed to research that has resulted in key policy and strategy change and is a member of various national and international technical and advisory committees and boards.

Dr. Mugala holds Bachelor of Science, Bachelor of Medicine and Surgery, and Master of Medicine degrees from the University of Zambia. She also has a Certificate in Epidemiology and Biostatistics from the Institute of Tropical Medicine in Antwerp, Belgium.

329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It

JLABS Bay Area

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit or follow @JNJInnovation.

Event contact

Related content